We evaluated the transport of Gadolinium-diethylenetriaminepentaacetate-bismethylamide (Gd-DTPA-BMA) through the round window (RW) membrane into the perilymphatic space with 4.7-T MRI in an animal study and 1.5-T MRI in humans. After administration of Gd-DTPA-BMA onto the intact RW membrane of guinea pig, Gd-DTPA-BMA uptake was observed in the basal turn and part of the second turn within 40 min. The scala tympani, scala vestibuli, the fibrous part of the spiral ligament and semicircular canal all showed uptake of Gd-DTPA-BMA. All turns of the cochlea were filled with Gd within 10 min in the perforated RW membrane administration group and within 30 min in the intravenous administration group. In patients who accepted middle ear injection of Gd-DTPA-BMA, uptake was observed within 2 h in the basal turn and semicircular canal. After 12 h the apex did still not show any uptake. Gd-DTPA-BMA is transported from the RW to the semicircular canal, the scala tympani and scala vestibuli without passing the helicotrema.

Keywords:
Gadolinium, Trans-ligamental pathway, Intratympanic treatment
1.
Goycoolea MV, Lundman L: Round window membrane. Structure function and permeability: A review. Microsc Res Tech 1997;36:201–211.
2.
Quaranta A, Scaringi A, Aloisi A, Quaranta N, Salonna I: Intratympanic therapy for Menière’s Disease: Effect of administration of low concentration of gentamicin. Acta Otolaryngol (Stockh) 2001;121:387–392.
3.
Pyykko I, Ishizaki H, Kaasinen S, Aalto H: Intratympanic gentamicin in bilateral Meniere’s disease. Otolaryngol Head Neck Surg 1994;110:162–167.
4.
Kaasinen S, Pyyko I, Ishizaki H, Aalto H: Intratympanic gentamicin in Meniere’s disease. Acta Otolaryngol 1998;118:294–298.
5.
Pfleiderer AG: The current role of local intratympanic gentamicin therapy in the management of unilateral Meniere’s disease. Clin Otolaryngol 1998;23:34–41.
6.
Charabi S, Thomsen J, Tos M: Round window gentamicin mu-catheter – a new therapeutic tool in Meniere’s disease. Acta Otolaryngol Suppl 2000;543:108–110.
7.
Hoffer ME, Kopke RD, Weisskopf P, Gottshall K, Allen K, Wester D, Balaban C: Use of the round window microcatheter in the treatment of Meniere’s disease. Laryngoscope 2001;111:2046–2049.
8.
Ohyama K, Salt AN, Thalmann R: Volume flow rate of perilymph in the guinea-pig cochlea. Hear Res 1988;35:119–129.
9.
Saijo S, Kimura RS: Distribution of HRP in the inner ear after injection into the middle ear cavity. Acta Otolaryngol 1984;97:593–610.
10.
Salt AN, Ohyama K, Thalmann R: Radial communication between the perilymphatic scalae of the cochlea. 1. Estimation by tracer perfusion. Hear Res 1991;56:29–36.
11.
Salt AN, Ohyama K, Thalmann R: Radial communication between the perilymphatic scalae of the cochlea. 2. Estimation by bolus injection of tracer into the sealed cochlea. Hear Res 1991;56:37–43.
12.
Salt AN, Ma Y: Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res 2001;154:88–97.
13.
Counter SA, Bjelke B, Borg E, Klason T, Chen Z, Duan ML: Magnetic resonance imaging of the membranous labyrinth during in vivo gadolinium (Gd-DTPA-BMA) uptake in the normal and lesioned cochlea. Neuroreport 2000;11:3979–3983.
14.
Zou J, Pyykkö I, Bretlau P, Klason T, Bjelke B: In vivo visualization of endolymphatic hydrops in guinea pigs: Magnetic resonance imaging evaluation at 4.7 tesla. Ann Otol Rhinol Laryngol 2003;112:1059–1065.
15.
Krasnow N: Effects of lanthanum and gadolinium ions on cardiac sarcoplasmic reticulum. Biochim Biophys Acta 1972;282:187–194.
16.
Pender DJ: Gentamicin tympanoclysis: Effects on the labyrinthine sensory cells. Laryngoscope 2003;113:343–348.
17.
Tonndorf J, Duvall AJ, Reneau JP: Permeability of intracochlear membrane to various vital stains. Ann Otol 1962;71:801–841.
18.
Duvall AJ 3rd, Quick CA, Sutherland CR: Horseradish peroxidase in the lateral cochlear wall. An electron microscopic study of transport. Arch Otolaryngol 1971;93:304–316.
19.
Franz P, Aharinejad S, Bock P, Firbas W: The cochlear glomeruli in the modiolus of the guinea pig. Eur Arch Otorhinolaryngol 1993;250:44–50.
20.
Penha R, O’Neill RA, Goyri O’Neill J, Esperanca Pina JA: Ultrastructural aspects of the microvasculature of the cochlea: The internal spiral network. Otolaryngol Head Neck Surg 1999;120:725–729.
21.
Tono T, Morimitsu T: Venous drainage through the internal auditory meatus of the guinea pig cochlea. Eur Arch Otorhinolaryngol 1992;249:28–33.
22.
Zou J, Pyykkö I, S Allen Counter, Klason T, Bretlau P, Bjelke B: In vivo observation of dynamic perilymph formation using 4.7-T MRI with gadolinium as a tracer. Acta Otolaryngol 2003;123:910–915.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.